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Abstract 
The risk of misdiagnosing neoplastic cells typically infiltrating an epithelium forming a 
lymphoepithelial lesion as poorly differentiated gastric cancer in endoscopic biopsies, 
particularly in low-grade mucosa-associated lymphoid tissue (MALT) lymphomas, is 
described. A 76-year-old woman was referred for management of a poorly differentiated 
gastric adenocarcinoma. Diagnostic endoscopy in our unit showed a 2 cm raised, submucosal 
lesion with central erosion in the upper body of the stomach, but repeat biopsies of the 
lesion were interpreted as inflamed gastric mucosa and negative for malignancy. Systematic 
gastric biopsies to rule out any foci of MALT lymphoma changes were also negative. 
Therefore, endoscopic submucosal dissection was performed to obtain an accurate 
specimen. Histology revealed centrocyte-like cells and a lymphoepithelial lesion invading 
into the mucosa with obliteration of the gastric glands, which was initially interpreted as 
poorly differentiated adenocarcinoma. 
  
Case Rep Gastroenterol 2012;6:47–51 
DOI: 10.1159/000336322 
Published online: 
January 25, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
 
48 
Introduction 
The gastrointestinal tract is the predominant site of extranodal non-Hodgkin 
lymphomas. Primary non-Hodgkin lymphomas of the gastrointestinal tract are rare, 
accounting for only 1–4% of malignancies arising in the stomach, small intestine or 
colon. Gastric lymphoma is the most common extranodal site of lymphoma. 
Mucosa-associated lymphoid tissue (MALT) lymphoma comprises 7–8% of all B-cell 
lymphomas and at least 50% of primary gastric lymphomas [1]. It reaches its peak 
incidence between the ages of 50 and 60 years and there is a slight male predominance. 
Patients with gastric MALT lymphoma typically present with nonspecific symptoms 
such as nausea, vomit, non-ulcer dyspepsia, epigastric discomfort, anorexia, weight 
loss, or occult gastrointestinal bleeding. Physical examination is often normal, but may 
reveal a palpable mass or peripheral lymphadenopathy when the disease is advanced. 
Laboratory studies also tend to be normal at presentation and anemia may be present 
in selected cases. The diagnosis should be confirmed by biopsy. Findings on upper 
endoscopy are diverse, including mucosal erythema, benign-appearing gastric ulcer or 
nodular lesion. Multiple biopsies should be obtained from both suspicious-appearing 
lesions and normal-appearing mucosa in the stomach since gastric MALT lymphoma 
can occasionally present as multifocal disease with involvement of tissue that appears 
to be unaffected on initial visualization. Conventional pinch biopsies may miss the 
diagnosis, since gastric MALT lymphoma can infiltrate the submucosa without affecting 
the mucosa. This problem is most likely to occur when no obvious mass is present. We 
should aim to attain the largest biopsy specimen possible. In epithelial tissues, MALT 
lymphomas are composed of morphologically heterogeneous small B-cells including 
marginal zone (centrocyte-like) cells, monocytoid cells, and small lymphocytes. The 
neoplastic cells typically infiltrate the epithelium forming a lymphoepithelial lesion 
(LEL) [2]. The risk of misdiagnosing such lesions as poorly differentiated gastric cancer 
in endoscopic biopsies, particularly in low-grade MALT lymphomas in which LEL may 
be particularly abundant, is well described [3]. 
Case Report 
A 76-year-old woman was referred for the management of poorly differentiated gastric 
adenocarcinoma diagnosed at the time of a routine screening upper endoscopy. She had been 
otherwise healthy and denied any recent anorexia or weight loss. Her past medical history was 
unremarkable and family history showed that her father had gastric cancer. Physical examination at 
presentation did not show any abdominal mass or palpable lymphadenopathy. Laboratory evaluation 
was likewise unrevealing. A diagnostic upper endoscopy in our unit revealed a 2 cm raised, 
submucosal lesion with central erosion in the upper body of the stomach (fig. 1). Repeat biopsies of 
the lesion were interpreted as inflamed gastric mucosa with positive Helicobacter pylori. We also 
performed systematic gastric biopsies to rule out any foci of MALT lymphoma changes within the 
stomach, however the results were not significant. Computed tomography of the chest and abdomen 
was negative for any lymphadenopathy or distant metastases. Based on the localized endoscopic 
findings and repeat negative biopsy results, we performed an endoscopic submucosal dissection 
(ESD) for diagnostic therapy. The resected specimen revealed a white, elastic, nodular, submucosal 
mass. Histological study revealed a well-circumscribed lymph follicle containing large germinal 
centers in the submucosa invading the muscularis mucosa and mucosa (fig. 2). Centrocyte-like cells 
and epitheliotropic proliferation (LEL) invading into the mucosa with obliteration of the gastric 
glands (fig. 3) were also seen. While the LEL was initially interpreted as poorly differentiated 
adenocarcinoma, the pathological evidence obtained from ESD established the diagnosis of a MALT  
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lymphoma of the stomach (c-stage IE). After eradication of H. pylori with antibiotics, the patient has 
had no local or distant recurrences during the subsequent 2 years of surveillance follow-up. 
Discussion 
The World Health Organization (WHO)/Revised European American Lymphoma 
(REAL) classification scheme groups all lymphomas involving extranodal sites 
(gastrointestinal tract, thyroid, lung, breast, orbit and skin) into the category of MALT 
lymphomas [4]. Although patients with gastric MALT lymphoma often present with 
stage I or II extranodal disease, those patients may have vastly different presentations 
depending on its size and location: asymptomatic, gastric outlet obstruction, or weight 
loss. Adding to the diagnostic challenge, there are no characteristic endoscopic findings 
[5]. Gastric MALT lymphoma often presents as multifocal disease within the stomach 
and systematic gastric biopsy is crucial for diagnosis. In this localized MALT lymphoma 
case, theoretically, since gastric MALT lymphomas develop from mucosa-associated 
lymphoid tissue, ESD should be adequate to obtain lymphoma tissue for the definite 
diagnosis. 
A previous study showed an association between previous H. pylori infection and 
the development of gastric MALT lymphoma and that eradication of H. pylori with 
antibiotics results in regression of gastric MALT lymphomas [6, 7]. This finding has 
been confirmed by others [8–10]. As gastric MALT lymphoma is classified as an 
indolent non-Hodgkin lymphoma, stable asymptomatic patients with persistently 
positive biopsies have been successfully followed until disease progression. 
In conclusion, we report a case of localized gastric MALT lymphoma diagnosed by 
ESD. ESD is a reasonable option for the diagnosis of localized gastric MALT lymphomas 
in selected cases in whom adequate tissue samples are difficult to obtain. 
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Fig. 1. Submucosal lesion of the stomach. 2 cm raised lesion with central erosion in the upper body of 
the stomach (indigo carmine stain). 
 
 
Fig. 2. Submucosal lymph node. Well-circumscribed submucosal lymph node invading the muscularis 
mucosa into the mucosa (H&E stain, ×1.25). 
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Fig. 3. LEL resembling poorly differentiated adenocarcinoma (H&E stain, ×40). 
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